CLINICAL_TRIALS
trial_result
· 2024-02-14
Clinical Trial Update: Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X) [Phase 3]
Summary
Phase 3 trial update for viltolarsen in ambulant boys with Duchenne muscular dystrophy (DMD).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NS Pharma, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: UNKNOWN